Organicell Regenerative Medici - SIC # 5122 - DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS SUNDRIES

Ticker Exchange SIC # Website Latest Ticker
OCEL Over the counter 5122 https://organicell.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Organicell Regenerative Medici

Recent Report Shows That Extracellular Vesicles Might Also Be Key To Stopping COVID, Colds, And Other Nasal Viruses - Dec 27th, 2022 1:00 pm
OTCMKTS : OCEL 📋 Organicell Starts Enrolling Long COVID Trial 😷 - Nov 22nd, 2022 4:33 pm
Organicell Regenerative Medicine, Inc. Responds to Recent Promotional Activities Pursuant to OTC Markets Request - Nov 21st, 2022 11:20 pm
Organicell Starts Enrolling Long COVID Trial - Nov 17th, 2022 1:30 pm
OTCMKTS : $OCEL 📋 Organicell Activates COPD Trial at Mayo Clinic! - Nov 16th, 2022 6:20 pm
Organicell Activates COPD Trial at Mayo Clinic - Nov 15th, 2022 1:30 pm
Can This Company’s Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval? - Nov 14th, 2022 2:17 pm
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier? - Nov 10th, 2022 7:17 pm
Organicell Regenerative Medicine, Inc. Announces Additions to Board of Directors - Oct 11th, 2022 2:15 pm
Organicell Regenerative Medicine, Inc. Announces Expansion of Management Team - Sep 20th, 2022 12:45 pm
Organicell Regenerative Medicine, Inc. Announces Expansion into Health and Beauty Market - Sep 16th, 2022 12:45 pm
BeautyHealth’s Hydrafacial Announces Partnership to Develop Breakthrough Exosome Booster - Sep 14th, 2022 4:50 pm
Organicell Regenerative Medicine, Inc. Secures Additional $11 Million in Financing in Preparation for Clinical Trial Enrollment - Sep 9th, 2022 12:45 pm
Organicell Regenerative Medicine, Inc. Engages Law Firm McDermott Will & Emery - Aug 30th, 2022 12:30 pm
Organicell Regenerative Medicine, Inc. Closes $5.5 Million Funding Round - Aug 26th, 2022 8:30 pm
Organicell Announces Matt Sinnreich as CEO - Jul 26th, 2022 11:30 am
Organicell Regenerative Medicine, Inc. Secures $4 Million in Funding for Clinical Trials and Agrees To Restructure Management - Jul 20th, 2022 11:30 am